Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents
- PMID: 27005666
- PMCID: PMC4810149
- DOI: 10.3390/pathogens5010028
Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents
Abstract
Ciprofloxacin works through interfering with replication and transcription of bacterial DNA, which leads to increased oxidative stress, and death of bacterial cells. Drugs with strong antioxidant such as tempol, melatonin and pentoxifylline might interfere with the antibacterial activity of ciprofloxacin. In the current study, the effect of these drugs on the cytotoxicity of ciprofloxacin was investigated against several reference bacteria. Standard bacterial strains included Escherichia coli ATCC 35218, Staphylococcus aureus ATCC29213, Pseudomonas aeruginosa ATCC 9027, Staphylococcus epidermidis ATCC 12228, Acinetobacter baumannii ATCC 17978, Proteus mirabilis ATCC 12459, Klebsiella pneumoniae ATCC 13883, methicillin-resistant Staphylococcus aureus (MRSA) (ATCC 43300), and Streptococcus pneumoniae (ATCC 25923). The antibacterial activity of ciprofloxacin with or without treatment of bacterial cells by tempol, melatonin or pentoxifylline was assessed using the disc diffusion method and by measuring the minimum inhibitory concentration (MIC) and zones of inhibition of bacterial growth. All of the tested bacterial strains were sensitive to ciprofloxacin. When treated with tempol, melatonin or pentoxifylline, all bacterial strains showed significantly smaller zones of inhibition and larger MIC values compared ciprofloxacin alone. In correlation, reactive oxygen species (ROS) generation induced by ciprofloxacin antibacterial action was diminished by treatment of bacterial cells with tempol, melatonin or pentoxifylline. In conclusion, results indicate the possible antagonistic properties for agents with antioxidant properties such as tempol, melatonin and pentoxifylline when they are used concurrently with flouroquinolones. This could be related to the ability of these agents to inhibit oxidative stress in bacterial cells.
Keywords: MIC; antimicrobial susceptibility; ciprofloxacin; melatonin; pentoxifylline; tempol.
Figures

Similar articles
-
Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.Clin Pharmacol. 2020 Oct 12;12:171-176. doi: 10.2147/CPAA.S268330. eCollection 2020. Clin Pharmacol. 2020. PMID: 33116949 Free PMC article.
-
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.Clin Pharmacol. 2017 Oct 17;9:119-124. doi: 10.2147/CPAA.S148448. eCollection 2017. Clin Pharmacol. 2017. PMID: 29081676 Free PMC article.
-
Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors.Curr Ther Res Clin Exp. 2014 Dec 5;77:14-7. doi: 10.1016/j.curtheres.2014.11.001. eCollection 2015 Dec. Curr Ther Res Clin Exp. 2014. PMID: 26649077 Free PMC article.
-
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
Cited by
-
Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity.Clin Pharmacol. 2020 Oct 12;12:171-176. doi: 10.2147/CPAA.S268330. eCollection 2020. Clin Pharmacol. 2020. PMID: 33116949 Free PMC article.
-
Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis.Sci Adv. 2025 Mar 7;11(10):eadt4723. doi: 10.1126/sciadv.adt4723. Epub 2025 Mar 5. Sci Adv. 2025. PMID: 40043104 Free PMC article.
-
Molecular docking studies of gyrase inhibitors: weighing earlier screening bedrock.In Silico Pharmacol. 2021 Jan 1;9(1):2. doi: 10.1007/s40203-020-00064-9. eCollection 2021. In Silico Pharmacol. 2021. PMID: 33442529 Free PMC article.
-
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin.Clin Pharmacol. 2017 Oct 17;9:119-124. doi: 10.2147/CPAA.S148448. eCollection 2017. Clin Pharmacol. 2017. PMID: 29081676 Free PMC article.
-
Atmospheric Carbon Dioxide Modifies the Antimicrobial Activity and Oxidative Stress Generated by Ciprofloxacin in Escherichia coli.Pathogens. 2025 Jul 14;14(7):689. doi: 10.3390/pathogens14070689. Pathogens. 2025. PMID: 40732735 Free PMC article.
References
-
- Al-Soud Y.A., Al-Masoudi N.A. A new class of dihaloquinolones bearing N′-aldehydoglycosylhydrazides, mercapto-1,2,4-triazole, oxadiazoline and á-amino ester precursors: Synthesis and antimicrobial activity. J. Braz. Chem. Soc. 2003;14:790–796. doi: 10.1590/S0103-50532003000500014. - DOI
-
- Oliphant C.M., Green G.M. Quinolones: A comprehensive review. Am. Fam. Physician. 2002;65:455–464. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases